Koji Kishimoto

3.4k total citations
122 papers, 2.7k citations indexed

About

Koji Kishimoto is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Koji Kishimoto has authored 122 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 28 papers in Pulmonary and Respiratory Medicine and 27 papers in Oncology. Recurrent topics in Koji Kishimoto's work include Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (12 papers) and Lymphoma Diagnosis and Treatment (10 papers). Koji Kishimoto is often cited by papers focused on Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (12 papers) and Lymphoma Diagnosis and Treatment (10 papers). Koji Kishimoto collaborates with scholars based in Japan, United States and China. Koji Kishimoto's co-authors include Guo-fu Hu, Takanori Tsuji, Mohamed H. Sayegh, Karen A. Olson, Shumei Liu, Akira Sasaki, Masayuki Sho, Norie Yoshioka, Toshiyuki Mitsuya and Hugh Auchincloss and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Koji Kishimoto

113 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koji Kishimoto Japan 30 1.1k 784 461 417 235 122 2.7k
Laurent Gros France 24 1.1k 1.0× 564 0.7× 274 0.6× 418 1.0× 171 0.7× 59 2.3k
Wei Sheng China 22 1.3k 1.1× 735 0.9× 330 0.7× 687 1.6× 206 0.9× 81 2.5k
Keisuke Kataoka Japan 31 1.2k 1.1× 718 0.9× 240 0.5× 683 1.6× 309 1.3× 145 3.0k
Anna Zagórska United States 23 1.4k 1.3× 1.1k 1.4× 270 0.6× 295 0.7× 254 1.1× 41 3.1k
Debra K. Newman United States 37 2.1k 1.9× 881 1.1× 608 1.3× 355 0.9× 194 0.8× 109 4.5k
Keith R. Anderson United States 27 1.6k 1.4× 657 0.8× 657 1.4× 293 0.7× 256 1.1× 37 3.2k
Shintaro Nakao Japan 41 2.0k 1.9× 892 1.1× 270 0.6× 555 1.3× 385 1.6× 214 5.5k
Tiziana Crepaldi Italy 28 1.5k 1.4× 279 0.4× 499 1.1× 416 1.0× 264 1.1× 70 2.9k
Liang Dong China 33 1.6k 1.5× 535 0.7× 486 1.1× 448 1.1× 556 2.4× 85 3.2k

Countries citing papers authored by Koji Kishimoto

Since Specialization
Citations

This map shows the geographic impact of Koji Kishimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Kishimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Kishimoto more than expected).

Fields of papers citing papers by Koji Kishimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Kishimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Kishimoto. The network helps show where Koji Kishimoto may publish in the future.

Co-authorship network of co-authors of Koji Kishimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Kishimoto. A scholar is included among the top collaborators of Koji Kishimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Kishimoto. Koji Kishimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Tanaka, Ryota, Masachika Fujiwara, Hitomi Kanno, et al.. (2023). Cytological characteristics of histological types of lung cancer by cytomorphometric and flow cytometric analyses using liquid‐based cytology materials. Diagnostic Cytopathology. 51(6). 356–364. 2 indexed citations
5.
Hotta, T, et al.. (2020). Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas. Journal of Cardiothoracic Surgery. 15(1). 149–149. 5 indexed citations
6.
Okui, Tatsuo, Tsuyoshi Shimo, Soichiro Ibaragi, et al.. (2018). Lactate Transporter Monocarboxylate Transporter 4 Induces Bone Pain in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 19(11). 3317–3317. 10 indexed citations
7.
Tate, Genshu, Takuma Tajiri, Koji Kishimoto, & Toshiyuki Mitsuya. (2014). A novel mutation of the axonemal dynein heavy chain gene 5 (DNAH5) in a Japanese neonate with asplenia syndrome. Medical Molecular Morphology. 48(2). 116–122. 4 indexed citations
8.
Yoshida, Shoko, Koji Kishimoto, Soichiro Ibaragi, et al.. (2012). A clinical study of patients aged 75 and older with oral squamous cell carcinoma. Journal of Japanese Society of Oral Oncology. 24(3). 103–111. 2 indexed citations
9.
Kishimoto, Koji, et al.. (2010). A case of cystadenocarcinoma arising in the retromolar region. Japanese Journal of Oral & Maxillofacial Surgery. 56(12). 720–724.
10.
Kishimoto, Koji, et al.. (2010). Spontaneous pneumothorax after radiation therapy for breast cancer: A case report. The Journal of the Japanese Association for Chest Surgery. 24(7). 1065–1068.
11.
Kishimoto, Koji, Takashi Kitamura, Takao Suzuki, et al.. (2005). Cytological differential diagnosis of follicular lymphoma grade 1 from reactive follicular hyperplasia-Focusing on distinctive features observed by Papanicolaou staining and immunocytochemical staining of bcl-2 protein-. The Journal of the Japanese Society of Clinical Cytology. 44(3). 118–123. 1 indexed citations
13.
Tate, Genshu, Takao Suzuki, Koji Kishimoto, & Toshiyuki Mitsuya. (2004). Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. Journal of Human Genetics. 49(4). 223–225. 36 indexed citations
14.
Sayegh, Mohamed H., Zihao Wu, Wayne W. Hancock, et al.. (2003). Allograft Rejection in a New Allospecific CD4+ TCR Transgenic Mouse. American Journal of Transplantation. 3(4). 381–389. 47 indexed citations
15.
Kishimoto, Koji, Sigrid Sandner, Jaime Imitola, et al.. (2002). Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. Journal of Clinical Investigation. 109(11). 1471–1479. 57 indexed citations
16.
Kishimoto, Koji, Sigrid Sandner, Jaime Imitola, et al.. (2002). Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. Journal of Clinical Investigation. 109(11). 1471–1479. 4 indexed citations
17.
Mese, Hiroshi, Akira Sasaki, Koji Kishimoto, et al.. (2002). Clinico-statistical analysis of mucoepidermoid carcinoma.. Journal of Japanese Society of Oral Oncology. 14(1). 11–16. 1 indexed citations
18.
Mandelbrot, Didier A., Koji Kishimoto, Hugh Auchincloss, Arlene H. Sharpe, & Mohamed H. Sayegh. (2001). Rejection of Mouse Cardiac Allografts by Costimulation in trans. The Journal of Immunology. 167(3). 1174–1178. 39 indexed citations
19.
Yamada, Akira, Koji Kishimoto, Victor Dong, et al.. (2001). CD28-independent Costimulation of T Cells in Alloimmune Responses. The Journal of Immunology. 167(1). 140–146. 104 indexed citations
20.
Kishimoto, Koji, Victor Dong, Shohreh Issazadeh‐Navikas, et al.. (2000). The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. Journal of Clinical Investigation. 106(1). 63–72. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026